Addition of a Gastrointestinal Microbiome Modulator to Metformin Improves Metformin Tolerance and Fasting Glucose Levels
Conclusion:
Combining a GI microbiome modulator with metformin might allow the greater use of metformin in T2D patients and improve treatment of the disease.
Source: Journal of Diabetes Science and Technology - Category: Endocrinology Authors: Burton, J. H., Johnson, M., Johnson, J., Hsia, D. S., Greenway, F. L., Heiman, M. L. Tags: Original Articles Source Type: research
More News: Diabetes | Diabetes Type 2 | Endocrinology | Fortamet | Gastroenterology | Metformin | Science | Study